MD
Mehul DamaFund Manager Since 6 Jul 2021
EquitySector - Healthcare
Nippon India Nifty Pharma ETF
3Y Annualised
22.00%
-0.32% 1D
Fund Performance
Fund Multiplier
Fund Info
Peer Comparison
Fund Managers
AMC Details
Performance
1M Returns
-0.79%
-0.32% 1D
Benchmark
SBI Nifty 10 yr Benchmark G-Sec ETF
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
This Fund
3 years 6 months
NIFTY 50
5 years 3 months
FD
9 years 7 months
Fund info
Fund size
₹1033.98 Cr
Min. SIP amount
₹1000
Min. Lumpsum amount
₹1000
Exit load
0%
Risk Profile
Very High Risk
Peer Comparison
This Fund's Performance Compared With Peers
Over the Period of oneMonth
1st
Nippon India Nifty Pharma ETF
-0.79%
2nd
Mirae Asset Healthcare Fund Direct Reinvestment of Income Distribution cum capital withdrawal
-0.91%
3rd
Mirae Asset Healthcare Fund Direct Payout of Income Distribution cum capital withdrawal
-0.91%
4th
Mirae Asset Healthcare Fund Direct Growth
-0.91%
5th
Mirae Asset Healthcare Fund Regular Growth
-1.02%
Fund Managers
About Nippon India Nifty Pharma ETF
Nippon India Nifty Pharma ETF is a Equity mutual fund scheme from Nippon Life India Asset Management Ltd. This fund has been in existence for 4 years, having been launched on 2021-07-06. Nippon India Nifty Pharma ETF has ₹1033.98 Cr worth of assets under management (AUM) as of Sat Dec 27 2025. The latest Net Asset Value (NAV) of Nippon India Nifty Pharma ETF as of Fri Dec 26 2025 is ₹23.2346. The fund has an expense ratio of 0.21%, which is medium comparable to most other Equity funds.
Nippon India Nifty Pharma ETF returns for the last 1 year are 0.37%. Since launch, it has delivered 11.27% average annual returns.
The Nippon India Nifty Pharma ETF has the majority of its money invested in Healthcare sectors.
Top 5 Holdings of Nippon India Nifty Pharma ETF.
- Sun Pharmaceuticals Industries Ltd: 23.17%
- Cipla Ltd: 10.34%
- Divi's Laboratories Ltd: 9.88%
- Dr Reddy's Laboratories Ltd: 9.21%
- Lupin Ltd: 6.05%
AMC Information
| Name | Nippon Life India Asset Management Ltd |
|---|---|
| Founding Date | 2021-07-06 |
| customercare@nipponindiaim.in | |
| Phone | 022-6808 7000/18602660111 |
| Website | https://mf.nipponindiaim.com/ |
| Address | Nippon Life India Asset Management Limited,4th Floor, Tower A, Peninsula Business Park,,Ganapatrao Kadam Marg,,Lower Parel (W) |
Tax Implications of Nippon India Nifty Pharma ETF
| Short Term Gains | 20% + applicable Surcharge + 4% Cess |
|---|---|
| Long Term Gains | 12.5% without indexation + applicable Surcharge + 4% Cess |
Similar Funds from Nippon Life India Asset Management Ltd
Nippon India Aggressive Hybrid Fund - Direct Plan - Growth Option
AllocationAggressive Allocation
3Y CAGR
16.23%
expense ratio
1.08%
fund size
₹4133.57 Cr
Nippon India ELSS Tax Saver Fund Direct Plan - Growth Option
EquityELSS (Tax Savings)
3Y CAGR
18.16%
expense ratio
1.02%
fund size
₹15519.07 Cr
Nippon India Multi Cap Fund - Direct Plan - Growth
EquityMulti-Cap
3Y CAGR
23.19%
expense ratio
0.71%
fund size
₹50048.30 Cr
Nippon India Equity Savings Direct Growth
AllocationEquity Savings
3Y CAGR
9.89%
expense ratio
0.74%
fund size
₹945.01 Cr
Nippon India Equity Savings Growth
AllocationEquity Savings
3Y CAGR
8.85%
expense ratio
1.79%
fund size
₹945.01 Cr
Calculate Your Returns
Estimated Returns in 3 Years (Based on past 3Y returns)
₹0
Total Amount
₹0
